Research and contact names

Revising the request- as I received too many proposals which did not demonstrate the requisite skills or experience - please send examples of work completed when resubmitting - I need somebody to undertake some online research (names, job titles, company name, and location ) 20 accounts - 5 contacts per account - formatted in a spreadsheet - please see brief below. Fixed rate. Please message me and I will explain more over Skype. Thanks - see below.



To determine fit - please provide a sample of 1-3 companies below or depending on how long it takes you to complete- Eli Lilly and Sanofi.

Please find me the name, and location (European only) for these job titles - if they detail what therapeutic, medicine, or biologic/drug they specialise in, please capture that detail as well.
That way we can determine if it's best to use my Linkedin or other databases to find 1st/2nd degree connections.

1. Head of Pharmacovigilance.
2. Head of Precision Medicine.
3. Head of Research and Development (Drug development)
4. Head of Data Science & Artificial Intelligence (AI)
5. Head of Real World Data/Evidence (RWD or RWE).

alternatives to head include: Director, President, Vice President, Officer

1. Pfizer — $253.2 billion
2. Roche — $212.5 billion
3. Merck & Co. — $198.7 billion
4. Novartis — $195.4 billion
5. AbbVie — $139.6 billion
6. Abbott Laboratories — $127 billion
7. Amgen — $124 billion
8. Eli Lilly — $122.6 billion
9. Novo Nordisk — $112.9 billion
10. Sanofi — $111.3 billion
11. AstraZeneca — $99.2 billion
12. GlaxoSmithKline — $98.2 billion
13. Bristol-Myers Squibb — $84.8 billion
14. Gilead Sciences — $80.9 billion
15. Bayer — $66.6 billion
16. CSL — $62.5 billion
17. Biogen — $60.6 billion
18. Merck KGaA — $46.2 billion
19. Allergan — $45.1 billion
20. Celgene — $44.8 billion
21. Vertex Pharmaceuticals — $42.3 billion
22. Shire — $42 billion
23. Regeneron Pharmaceuticals — $40.4 billion
24. Chugai Pharmaceuticals — $31.5 billion
25. Jiangsu Hengrui Medicine Co. — $29.4 billion